Citation Impact
Citing Papers
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
1997
Functional Extinction of Birds Drives Rapid Evolutionary Changes in Seed Size
2013 StandoutScience
The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults
2002
Resilience and Sustainable Development: Building Adaptive Capacity in a World of Transformations
2002 Standout
Incidence and impact of resistance against approved antiretroviral drugs
2000
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Agricultural sustainability and intensive production practices
2002 StandoutNature
Clinical Pharmacokinetics of Lamivudine
1999
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Coupled Human and Natural Systems
2007 StandoutNobel
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Tumor acidity, ion trapping and chemotherapeutics
2003
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Recent progress in the development of coumarin derivatives as potent anti‐HIV agents
2003 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy
1987
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
2006 Standout
Human Immunodeficiency Virus Type 1 Expressing the Lamivudine‐Associated M184V Mutation in Reverse Transcriptase Shows Increased Susceptibility to Adefovir and Decreased Replication Capability In Vitro
1999
Chronic hepatitis B
2007 Standout
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication
2004
Nucleoside Reverse Transcriptase Inhibitor Resistance
2001
What is meant by intention to treat analysis? Survey of published randomised controlled trials
1999 Standout
Occurrence, fate and effects of pharmaceutical substances in the environment- A review
1998 Standout
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study
2000
Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine
1998
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects
2005 StandoutNobel
Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel
2003
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
Defining the Anthropocene
2015 StandoutNature
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Occupational exposure to antineoplastic agents at several departments in a hospital
1992 Standout
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Astroglia as Metal Depots: Molecular Mechanisms for Metal Accumulation, Storage and Release
2001
Effects of selective inhibition of protein kinase C, cyclic AMP‐dependent protein kinase, and Ca2+‐calmodulin‐dependent protein kinase on neurite development in cultured rat hippocampal neurons
1993
Reaching for a sustainable, resilient urban future using the lens of ecosystem services
2012 Standout
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
1982
Biodiversity Conservation and the Eradication of Poverty
2004 StandoutScience
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection
2000
A counting renaissance: combining stochastic mapping and empirical Bayes to quickly detect amino acid sites under positive selection
2012
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
PATHOGEN POPULATION GENETICS , EVOLUTIONARY POTENTIAL, AND DURABLE RESISTANCE
2002 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Nucleoside Reverse Transcriptase Inhibitor Resistance
2001
A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in Nurses
1985 Standout
Climate Warming and Disease Risks for Terrestrial and Marine Biota
2002 StandoutScience
Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10
2018 Standout
Defaunation in the Anthropocene
2014 StandoutScience
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 StandoutScience
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
2002 Standout
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
2005
2015 update of the drug resistance mutations in HIV-1
2015
Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization.
1994 StandoutNobel
OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDE
1984
Humans as the World's Greatest Evolutionary Force
2001 Science
Works of David Shugarts being referenced
Resistance Mutations in Protease and Reverse Transcriptase Genes of Human Immunodeficiency Virus Type 1 Isolates from Patients with Combination Antiretroviral Therapy Failure
1998
Organic and inogranic lead inhibit neurite growth in vertebrate and invertebrate neurons in culture
1989
Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy
2000
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients
1996
Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
1981
Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy
2000
Phenotypic and Genotypic Analysis of Biologically Cloned Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Zidovudine and Lamivudine
2002
Effects of inorganic lead on the differentiation and growth of cultured hippocampal and neuroblastoma cells.
1991